Cargando…
Mortality and Costs Associated with Wearable Cardioverter-defibrillators after Acute Myocardial Infarction: A Retrospective Cohort Analysis of Medicare Claims Data
Ventricular arrhythmias are common in the early period after myocardial infarction (MI), with the highest risk occurring in the immediate postinfarct window. The wearable cardioverter-defibrillator (WCD) has been proven to have efficacy in treating sudden cardiac arrest in patients soon after MI. Ho...
Autores principales: | Clark, Mary Ann, Szymkiewicz, Steven J., Volosin, Kent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252700/ https://www.ncbi.nlm.nih.gov/pubmed/32477706 http://dx.doi.org/10.19102/icrm.2019.101007 |
Ejemplares similares
-
Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013) -
PO-632-07 EFFECTIVENESS OF THE WEARABLE CARDIOVERTER DEFIBRILLATOR IN PATIENTS WITH COVID-19
por: Bianco, Nicole, et al.
Publicado: (2022) -
Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016) -
First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011) -
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)